Imaging of the serotonergic system: Interactions of neuroanatomical and functional abnormalities of depression

Biological Psychiatry

Volumn 44, Issue 7, 1998, Pages 534-549

  Staley, Julie K ^a,b   Malison, Robert T ^c   Innis, Robert B ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Yale University School of Medicine   (United States)

Author keywords

Depression; Positron emission tomography; Serotonin receptors; Serotonin transporter; Single photon emission computed tomography; Tryptophan hydroxylase

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (2 FLUOROETHYL)SPIPERONE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; FANANSERIN; FENFLURAMINE; FLUOROETHYLKETANSERIN; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; R 91150; R 93274; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SETOPERONE; TRACER; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG;

ARTICLE; DEPRESSION; DIAGNOSTIC IMAGING; IMAGING SYSTEM; ISOTOPE LABELING; NEUROANATOMY; PATHOGENESIS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNAPTIC TRANSMISSION;

EID: 0032191771     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00185-1     Document Type: Review

References (145)

1. 3H-Imipramine binding in the frontal cortex of suicides. Psychiatry Res 30:125-135.
2. Arora R, Meltzer H (1989b): Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146: 730-736.
3. 3H-imipramine binding" studies in the frontal cortex of normal controls and suicide victims. Biol Psychiatry 29:1016-1022.
4. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V (1976): "Serotonin depression" - A biochemical subgroup within the affective disorders. Science 191:478-480.
5. Axelson D, Doraiswamy P, McDonald W, et al (1993): Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 47:163-173.
6. Azmitia E, Whitaker-Azmitia P (1991): Awakening the sleeping giant: Anatomy and plasticity of the brain serotonergic system. J Clin Psychiatry 52(suppl 12):4-16.
7. 2 receptor antagonist. In: Hartmann A, Hoyer S, editors. Cerebral Blood Flow and Metabolism Measurement. New York: Springer-Verlag, p 471-480.
8. Baxter L, Phelps M, Mazziottas J, et al (1985): Cerebral metabolic rates for glucose in mood disorders, studied with positron emission tomography (PET) and (F-18)-fluro-2-deoxyglucose (FDG). Arch Gen Psychiatry 42:441-447.
9. Baxter L, Schwartz J, Phelps M, et al (1989): Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243-250.
10. Bench C, Fristen K, Brown R, Scott L, Frackowiak R, Dolan R (1992): The anatomy of melancholia: Focal abnormalities of cerebral blood flow in major depression. Psychol Med 22: 607-615.
11. Bench C, Friston K, Brown R, Frackowiak R, Dolan R (1993): Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions. Psychol Med 23:579-590.
12. Bergstrom K, Halldin C, Hall H, et al (1997): In vitro and in vivo characterization of nor-β-CIT: A potential radioligand for visualization of the serotonin transporter in the brain. Eur J Nucl Med 24:596-601.
13. 18F]RP62203: A selection 5-HT2A receptor radioligand for positron emission tomography. Nucl Med Biol 23:169-171.
14. Bever K, Perry P (1976): Dexfenfluramine hydrochloride: An anorexigenic agent. Am J Health Syst Pharm 54:2059-2072.
15. 2 receptors in humans using positron emission tomography. Eur J Nucl Med 21:937-946.
16. 2 receptor imaging in major depression: Focal changes in orbitor-insular cortex. Br J Psychiatry 171:444-448.
17. 18F]Setoperone: A new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. Eur J Pharmacol 147:73-82.
18. 18F-labeled setoperone. J Neurochem 54:1744-1754.
19. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12:27-36.
20. Bonvento G, Lacombe P (1993): Serotonin and the Cerebral Circulation. Boca Raton, FL: CRC Press.
21. Bonvento G, MacKenzie E (1997): Serotonin and its receptors. In: Welch KMA, editor. Primer on Cerebrovascular Diseases. New York: Academic Press, pp 80-82.
22. Bowen D, Najlerahim A, Procter A, Francis P, Murphy E (1989): Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of late life. Proc Natl Acad Sci USA 86:9504-9508.
23. Bremner D, Innis R, Salomon R, et al (1997): Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54:364-373.
24. Briley M, Langer S, Raisman R, Sechter S, Zarifian E (1980): Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209:303-305.
25. Buchsbaum M, Wu J, DeLisi L, et al (1986): Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with F2-deoxyglucose in affective illness. J Affect Disorder 10:137-152.
26. Busatto G (1996): Radioligands for brain 5-HT2 receptor imaging in vivo: Why do we need them? Eur J Nucl Med 23:867-870.
27. Busatto G, Pilowsky L, Costa D, et al (1997): Initial evaluation of 123I-5-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. Eur J Nuc Med 24:119-124.
28. Cheetham S, Crompton M, Katona C, Horton R (1988): Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443:272-280.
29. Cheetham S, Crompton M, Katona C, Horton R (1990): Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology (Berl) 102:544-548.
30. Coffey C, Wilkinson W, Weiner R, et al (1993): Quantitative cerebral anatomy of depression: A controlled magnetic resonance imaging study. Arch Gen Psychiatry 50:7-16.
31. Collier D, Stober G, Li T, et al (1996): A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Mol Psychiatry 1;453-460.
32. Cook E, Metz J, Cooper M, Chou J, Leventhal B (1992): Fenfluramine and cerebral glucose. Biol Psychiatry 31:1173-1174.
33. Cook E, Metz J, Leventhal B, et al (1994): Fluoxetine effects on cerebral glucose metabolism. Neuroreport 5:1745-1458.
34. Cooper J, Bloom F, Roth R (1996): The Biochemical Basis of Neuropharmacology, 7th ed. New York: Oxford University Press.
35. Cooper S, Owen F, Chambers D, Crow T, Johnston J, Poulter M (1986): Post-mortem neurochemical findings in suicide victims and depression: A study of the serotonergic system and imipramine binding in suicide victims. In: Deakin J, editor. The Biology of Depression. London: Gaskell Press, pp 53-71.
36. Cowen P (1991): Serotonin receptor subtypes: Implications for psychopharmacology. Br J Psychiatry 159(suppl 12):7-14.
37. Crow T, Cross A, Cooper S, et al (1984): Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23:1561-1569.
38. Darchen F, Scherman D, Ladyrib P, Henry J (1988): Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles. Mol Pharmacol 33:672-677.
39. Delgado P, Charney D, Price L, Aghajanian G, Andes H, Heninger G (1990): Serotonin function and the mechanism of antidepressant action. Reversal of anti-depressant induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411-418.
40. Dewey S, Smith G, Logan J, et al (1995): Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neurosci 15:821-829.
41. D'Haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijsemans M, Kaufman L (1992): SPECT imaging of 5-HT2 receptors in depression. Psychiatry Res 45:227-237.
42. Diksic M, Nagahiro S, Sourkes T, Yamamoto Y (1990): A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J Cereb Blood Flow Metab 10:1-12.
43. Diksic M, Nagahiro S, Chaly T, Sourkes T, Yamamoto Y, Feindel W (1991): Serotonin synthesis rate measured in living dog brain by positron emission tomography. J Neurochem 56:153-162.
44. Dolan R, Bench C, Brown R, Scott LC, Friston K, Frackowiak R (1992): Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry 55:768-773.
45. Drevets W (1998): Functional neuroimaging studies of depression: The anatomy of melancholia. Annu Rev Med 49:331-361.
46. Drevets W, Raichle M (1992a): Neuroanatomical circuits in depression: Implications for treatment mechanisms. Psychopharmacol Bull 128:261-274.
47. Drevets W, Videen T, Preskorn S, Carmichael T, Raichle M (1992b): A functional anatomical study of unipolar depression. J Neurosci 12:3628-3641.
48. Drevets W, Price J, Simpson J, et al (1997): Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386;824-827.
49. Elliott J (1991): Peripheral markers in affective disorders. In: Horton R, Katona C, editors. Biological Aspects of Affective Disorders, London: Academic Press, pp 95-144.
50. Ellis P, Salmond C (1994): Is platelet imipramine binding reduced in depression? A meta analysis. Biol Psychiatry 36:292-299.
51. Ferrier I, McKeith I, Cross A, Perry E, Candy J, Perry R (1990): Postmortem neurochemical studies in depression. Ann NY Acad Sci 487:128-142.
52. Fornal C, Radulavacki M (1983): Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation. J Pharmacol Exp Ther 225:667-674.
53. Freo U, Pietrini P, Pizzloator G, Dam M, Ruggero S, Battistin L (1991): Effects of clomipramine on local glucose metabolism in awake rats. Biol Psychiatry 29:2048.
54. Frost J (1990): Imaging the serotonergic system by positron emission tomography. Ann NY Acad Sci 600:273-280.
55. Fuller R (1986): Biochemical pharmacology of the serotonin system. Adv Neurol 43:469-480.
56. Geaney D, Soper N, Shepstone B, Goodwin G, Cowen P (1991): Intravenous L-tryptophan and regional cerebral blood flow. Biol Psychiatry 29:508-509.
57. George M, Ketter T, Post R (1993): SPECT and PET imaging in mood disorders. J Clin Psychiatry 54:6-13.
58. George M, Ketter T, Post R (1994): Prefrontal cortex dysfunction in clinical depression. Depression 2:59-72.
59. 11C]WAY-100635, in monkey and human plasma by HPLC: Comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. Nucl Med Biol 23:627-634.
60. Golden R, Gilmore J, Ekdsstrom R, et al (1996): The effects of age, gender, and season on serotonergic function in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry 20: 1315-1323.
61. 99mTC-exametazine with single photon emission tomography in major depression before and after treatment. J Affect Disord 29:243-253.
62. Gross-Isseroff R, Israeli M, Biegon A (1989): Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: Effects of suicide. Arch Gen Psychiatry 46: 237-241.
63. 11C]WAY-100635. Brain Res 745:96-108.
64. 4 receptor. Eur J Pharmacol 314:229-233.
65. Horton R (1992): The neurochemistry of depression: Evidence derived from studies of post-mortem brain tissue. Mol Aspects Med 13:191-203.
66. Hume S, Pascali C, Pike V, et al (1991): Citalopram: Labelling with carbon-11 and evaluation in rats as a potential radioligand for in vivo PET studies of 5-HT re-uptake sites. Nucl Med Biol 18:339-351.
67. 2A receptors with carbon-11-MDL 100,907. J Nucl Med 39:208-214.
68. Jacobs B, Azmitia E (1992): Structure and function of the brain serotonergic system. Physiol Rev 72:165-229.
69. Jagust W, Eberling J, Biegon A, et al (1995): Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. J Nucl Med 37:1207-1214.
70. Jovkar S, Wienhard K, Coenen H, Pawlik G, Heiss W (1991): Quantification of baboon cortical S2 serotonin receptors in vivo with 3-N-(2′-F18)fluoroethylspiperone and positron emission tomography. Eur J Nucl Med 18:158-163.
71. Kapur S, Meyer J, Wilson A, Houle S, Brown G (1994): Modulation of cortical neuronal activity by a serotonergic agent: A PET study in humans. Brain Res 646:292-294.
72. 1A receptor antagonist. Brain Res 673:217-225.
73. Krishnan K, McDonald W, Escalona R, et al (1992): Magnetic resonance imaging of the caudate nuclei in depression. Arch Gen Psychiatry 49:553-557.
74. Kuikka J, Tihonen J, Bergstrom K, et al (1995): Imaging of serotonin and dopamine transporters in the living human brain. Eur J Nucl Med 22:346-350.
75. Laruelle M, Abi-Dargham A, Casanova M, Toti R, Weinberger D, Kleinman J (1993a): Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: A postmortem study. Arch Gen Psychiatry 50:810-818.
76. 123I] β-CIT: Pharmacological characterization of brain uptake in nonhuman primates. Synapse 13:295-309.
77. Laruelle M, Iyer R, Al-Tikriti M, et al (1997): Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 25:1-14.
78. 3H]paroxetine, in antidepressant-free depressed suicides. Brain Res 526:17-22.
79. 3H-paroxetine binding sites in postmortem human brain from controls and suicides. Biol Psychiatry 28:544-546.
80. Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L (1991): Fluorine-18-altanserin: A radioligand for the study of serotonin receptors with PET: Radiolabeling and in vivo biologic behavior in rats. J Nucl Med 32:2266-2272.
81. Lesch K, Wolozin B, Murphy D, Reiderer P (1993): Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J Neurochem 60:2319-2322.
82. 2 receptors. Nucl Med Biol 16:697-704.
83. Leysen J (1989): Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites. In: Boulton A, Baker G, Jurio A, editors. Drugs as Tools in Neurotransmitter Research. Clifton, NJ: The Humana Press, pp 299-350.
84. 125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain. J Neurochem 61:1996-2006.
85. Little K, McLaughlin D, Ranc J, et al (1997): Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol Psychiatry 41:1156-1164.
86. 11C]dapoxetine HCl, a serotonin reuptake inhibitor: Biodistribution in rat and preliminary PET imaging in the monkey. Nucl Med Biol 21:669-675.
87. 2 receptors in suicide victims: Violence of death, depression, and effects of antidepressant treatment. Brain Res 642:281-289.
88. Lundkvist C, Halldin C, Ginovart N, et al (1996): [11C]MDL 100907, a radioligand for selective imaging of 5-HT2A receptor with positron emission tomography. Life Sci 58:187-192.
89. Maes M, Meltzer H (1995): The serotonin hypothesis of major depression. In: Bloom F, Kupfer D, editors. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 933-944.
90. 123I]β-CIT SPECT. Biol Psychiatry.
91. Malizia A, Melichar J, Brown D, et al (1997): Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo. J Psychopharmacol 11:279-281.
92. Mann J, Stanley P, McBride P, McEwen B (1986): Increased serotonin2 and beta receptor in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954.
93. Mann J, McBride P, Stanley M (1990): Postmortem monoamine receptor and enzyme studies in suicide. Ann NY Acad Sci 487:114-121.
94. Mann J, Malone K, Diehl D, Perel J, Cooper T, Mintun M (1996): Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 153:174-182.
95. Martinet J, Hardy P, Feline A, et al (1990): Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am J Psychiatry 147:1313-1317.
96. Massou J, Trichard C, Attar-Leny D, et al (1997): Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology (Berl) 133:99-101.
97. Mayberg H (1994): Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci 6:428-442.
98. Mayberg H, Robinson R, Wong D, et al (1988): PET imaging of the cortical S2 serotonin receptor after stroke: Lateralized changes and relationship to depression. Am J Psychiatry 145:937-943.
99. Mayberg H, Parikh R, Morris P, Robinson R (1991): Spontaneous remission of post-stroke depression and temporal changes in cortical S2-serotonin receptors. J Neuropsychiatry Clin Neurosci 3:80-83.
100. Mayberg H, Lewis P, Regenold W, Wagner H (1994): Paralimbic hypoperfusion in unipolar depression. J Nucl Med 35:929-934.
101. Mayberg H, Brannan S, Mahurin RK, et al (1997): Cingulate function in depression: A potential predictor of treatment response. Neuroreport 8:1057-1061.
102. McBride P, Tierney H, DeMeo M, Chen J, Mann J (1990): Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 27:1143-1155.
103. McKeith I, Marshall E, Ferrier I, et al (1987): 5-HT receptor binding in post-mortem brains from patients with affective disorder. J Affect Disord 13:67-74.
104. Mellerup E, Plenge P (1990): Why some depressed patients may have low platelet 3H-imipramine binding. Acta Psychiatr Scand 82:330:334.
105. Meltzer H (1990): Role of serotonin in depression. Ann NY Acad Sci 487:486-500.
106. 2 receptors, a promising tracer for γ-emission tomography. J Labeled Compd Radiopharm 34: 795-806.
107. 2O PET study in humans. Neurosci Lett 207:25-28.
108. Meyerson L, Wennogle L, Abel M, et al (1982): Human brain alterations in suicide victims. Pharmacol Biochem Behav 17:159-163.
109. 18F]fluoroethyl-ketanserin and PET. Neurosci Lett 123:23-26.
110. Nagahiro S, Takada A, Diksic M, Sourkes T, Missala K, Yamamoto Y (1990): A new method to measure brain serotonin synthesis in vivo. II. A practical autoradiographic method tested in normal and lithium treated rats. J Cereb Blood Flow Metab 10:13-21.
111. Nagao T, Ibayashi S, Sadoshima S, Izum J, Fujishma M (1995): Citalopram, a serotonin reuptake inhibitor, and brain ischemia in SHR. Brain Res Bull 38:49-52.
112. Nishizawa S, Benkelfat C, Young S, et al (1997): Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 94:5308-5313.
113. Ogilvie A, Battersby S, Bubb V, et al (1996): Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347:731-737.
114. 11C]WAY-100634, in monkey. J Labeled Compd Radiopharm 37:283.
115. Owen F, Cross A, Crow T, et al (1983): Brain 5-HT2 receptors and suicide. Lancet 11:1256.
116. Owen F, Chambers D, Cooper S, Johnson J, Lofthouse R, Poulter M (1986): Serotonergic mechanisms in brains of suicide victims. Brain Res 362:185-188.
117. Owens M, Nemeroff C (1994): Role of serotonin in the pathophysiology of depression. Clin Chem 40:288-295.
118. Owens M, Morgan W, Plott S, Nemeroff C (1997): Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-1322.
119. Palacios J, Waeber C, Mengod G, Pompeiano M (1991): Molecular neuroanatomy of 5-HT receptors. In: Fozard J, Saxena P, editors. Sertonin: Molecular Biology, Receptors and Functional Effects. Basel: Birkhauser Verlag, pp 5-20.
120. Paul S, Rehavi M, Skolnick P, Goodwin F (1984): High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet: Studies in depression. In: Post RM, Bellinger JC, editors. Neurobiology of Mood Disorders. Baltimore: Williams and Wilkins, pp 845-853.
121. Perlmutter J, Moerlein S, Hwang D, Todd R (1991): Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: Specificity analysis and comparison with in vitro binding. J Neurosci 11:1381-1389.
122. Perry E, Marshall E, Blessed G, Tomlinson B, Perry R (1983): Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry 142:188-192.
123. Petit-Taboue M, Landeau B, Osmont A, Tillet I, Barre L, Baron J (1996): Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis. J Nucl Med 37:95-104.
124. 11C]WAY-100635. Med Chem Res 5:208.
125. 11C]WAY-100635. Eur J Pharmacol 283:R1-R3.
126. 11C]WAY-100635. Eur J Pharmacol 301:R5-R7.
127. Pirker W, Asenbaum S, Kasper S, et al (1995): β-CIT SPECT demonstrates blockade of 5-HT-uptake site by citalopram in the human brain in vivo. J Neural Transm Gen Sect 100:247-256.
128. Post R, Lisi LD, Holcomb H, Uhde T, Cohen R, Buchsbaum M (1987): Glucose utilization in the temporal cortex of affectively ill patients: Positron emission tomography. Biol Psychiatry 22:545-553.
129. 18F]altanserin: Results in young normal controls. J Cereb Blood Flow Metab 15:787-797.
130. 2 receptor agent. Nucl Med Biol 24:295-303.
131. 11-fluoxetine as in vivo ligands for the serotonin uptake site. [Abstract]. J Nucl Med 31:883.
132. Shah S, Doraiswamy P, Husain M, et al (1992): Posterior fossa abnormalities in major depression: A controlled magnetic resonance imaging study. Acta Psychiatr Scand 85:474-479.
133. Sharpley A, Cowen P (1995): Effect of pharmacologic treatment on the sleep of depressed patients. Biol Psychiatry 37:85-98.
134. 11C]fluoxetine in a monkey brain. Nucl Med Biol 22:613-616.
135. 1A receptors in humans. Synapse 25:147-154.
136. 125I]RTI-55. JNeurochem 62:549-556.
137. Stanley M, Mann J (1983): Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet i:214-216.
138. Stanley M, Virgilio J, Gershon S (1982): Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337-1339.
139. Stanley M, Mann J, Cohen L (1986): Serotonin and serotonergic receptors in suicide. Ann NY Acad Sci 487:122-127.
140. Suehiro M, Scheffel U, Dannals R, Ravert H, Ricaurte G, Wagner H (1993): A PET radiotracer for studying serotonin uptake sites: Carbon-11-McN-5652Z. J Nucl Med 34:120-127.
141. 11C](+)McN5652. Synapse 20:37-43.
142. Villemangne V, Dannals R, Sanchez R, et al (1989): PET imaging of central serotonin re-uptake sites in the baboon brain with [C-11]-N-Me paroxetine (C-11-MPx) [abstract]. J Nucl Med 30:1160.
143. 11C]-methyl)-2-Br-LSD. Synapse 1:393-398.
144. 2 receptor changes in major depression. Biol Psychiatry 27:489-496.
145. Young S, Smith S, Pihl R, Ervin F (1985): Tryptophan depletion causes a rapid lowering of mood in normal subjects. Psychopharmacology (Berl) 87:173-177.